Abdominal Aortic Aneurysm Market to Observe Impressive Growth During the Forecast Period (2022-2032), Evaluates DelveInsight | Key Companies – Merck Serono, AstraZeneca, RSPR Pharma AB, Merck

Posted on
by

Abdominal Aortic Aneurysm Market to Observe Impressive Growth During the Forecast Period (2022-2032), Evaluates DelveInsight | Key Companies - Merck Serono, AstraZeneca, RSPR Pharma AB, Merck
DelveInsight’s “Abdominal Aortic Aneurysm Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Abdominal Aortic Aneurysm.

DelveInsight’s “Abdominal Aortic Aneurysm Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Abdominal Aortic Aneurysm, historical and forecasted epidemiology as well as the Abdominal Aortic Aneurysm market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

To Know in detail about the Abdominal Aortic Aneurysm market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Abdominal Aortic Aneurysm Market Forecast

 

Some of the key facts of the Abdominal Aortic Aneurysm Market Report: 

  • The Abdominal Aortic Aneurysm market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
  • As per the study conducted by Palma M. Shaw et al. (2019), the prevalence of abdominal aortic aneurysms increases after age 60, and it peaks in the seventh and eighth decades of life
  • In 2019, Public Health England (PHE) reported that approximately 0.97% of men screened had an AAA, although this value varied from 0.66% to 1.77% depending on geographical location (PHE2019)
  • Every year, 200,000 people in the U.S. are diagnosed with an abdominal aortic aneurysm (AAA)
  • Key Abdominal Aortic Aneurysm Companies: Merck Serono, AstraZeneca, RSPR Pharma AB, Merck Serono GmbH, Medtronic, Cardiatis S.A., Cardinal Health, Inc., Cook Medical, Inc., Endologix LLC, JOTEC GmbH, Lombard Medical, Inc., Medtronic plc, Inside Medical, W. L. Gore & Associates, Inc., MicroPort Scientific Corporation, and others
  • Key Abdominal Aortic Aneurysm Therapies: Metformin Glucophage, Ticagrelor, CRD007, Metformin Glucophage, Telmisartan, and others
  • The Abdominal Aortic Aneurysm epidemiology based on gender analyzed that Abdominal aortic aneurysms are more common in men
  • The Abdominal Aortic Aneurysm market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Abdominal Aortic Aneurysm pipeline products will significantly revolutionize the Abdominal Aortic Aneurysm market dynamics.

 

Abdominal Aortic Aneurysm Overview

Abdominal Aortic Aneurysm (AAA) is a localized enlargement of the abdominal aorta such that the diameter is greater than 3 cm or more than 50% larger than usual. It occurs when atherosclerosis or plaque buildup causes the walls of the abdominal aorta to become weak and bulge outward like a balloon. It develops slowly over time and has few noticeable symptoms.

 

Get a Free sample for the Abdominal Aortic Aneurysm Market Report – 

https://www.delveinsight.com/sample-request/abdominal-aortic-aneurysm-market

 

Abdominal Aortic Aneurysm Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Abdominal Aortic Aneurysm Epidemiology Segmentation:

The Abdominal Aortic Aneurysm market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Abdominal Aortic Aneurysm
  • Prevalent Cases of Abdominal Aortic Aneurysm by severity
  • Gender-specific Prevalence of Abdominal Aortic Aneurysm
  • Diagnosed Cases of Episodic and Chronic Abdominal Aortic Aneurysm

 

Download the report to understand which factors are driving Abdominal Aortic Aneurysm epidemiology trends @ Abdominal Aortic Aneurysm Epidemiology Forecast

 

Abdominal Aortic Aneurysm Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Abdominal Aortic Aneurysm market or expected to get launched during the study period. The analysis covers Abdominal Aortic Aneurysm market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Abdominal Aortic Aneurysm Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Abdominal Aortic Aneurysm Therapies and Key Companies

  • Metformin Glucophage: Merck Serono
  • Ticagrelor: AstraZeneca
  • CRD007: RSPR Pharma AB
  • Metformin Glucophage: Merck Serono GmbH
  • Telmisartan: Medtronic

 

Discover more about therapies set to grab major Abdominal Aortic Aneurysm market share @ Abdominal Aortic Aneurysm Treatment Market

 

Scope of the Abdominal Aortic Aneurysm Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Abdominal Aortic Aneurysm Companies: Merck Serono, AstraZeneca, RSPR Pharma AB, Merck Serono GmbH, Medtronic, Cardiatis S.A., Cardinal Health, Inc., Cook Medical, Inc., Endologix LLC, JOTEC GmbH, Lombard Medical, Inc., Medtronic plc, Inside Medical, W. L. Gore & Associates, Inc., MicroPort Scientific Corporation, and others
  • Key Abdominal Aortic Aneurysm Therapies: Metformin Glucophage, Ticagrelor, CRD007, Metformin Glucophage, Telmisartan, and others
  • Abdominal Aortic Aneurysm Therapeutic Assessment: Abdominal Aortic Aneurysm current marketed and Abdominal Aortic Aneurysm emerging therapies
  • Abdominal Aortic Aneurysm Market Dynamics: Abdominal Aortic Aneurysm market drivers and Abdominal Aortic Aneurysm market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Abdominal Aortic Aneurysm Unmet Needs, KOL’s views, Analyst’s views, Abdominal Aortic Aneurysm Market Access and Reimbursement 

 

To know more about Abdominal Aortic Aneurysm companies working in the treatment market, visit @ Abdominal Aortic Aneurysm Clinical Trials and Therapeutic Assessment

 

Table of Contents 

1. Abdominal Aortic Aneurysm Market Report Introduction

2. Executive Summary for Abdominal Aortic Aneurysm

3. SWOT analysis of Abdominal Aortic Aneurysm

4. Abdominal Aortic Aneurysm Patient Share (%) Overview at a Glance

5. Abdominal Aortic Aneurysm Market Overview at a Glance

6. Abdominal Aortic Aneurysm Disease Background and Overview

7. Abdominal Aortic Aneurysm Epidemiology and Patient Population

8. Country-Specific Patient Population of Abdominal Aortic Aneurysm 

9. Abdominal Aortic Aneurysm Current Treatment and Medical Practices

10. Abdominal Aortic Aneurysm Unmet Needs

11. Abdominal Aortic Aneurysm Emerging Therapies

12. Abdominal Aortic Aneurysm Market Outlook

13. Country-Wise Abdominal Aortic Aneurysm Market Analysis (2019–2032)

14. Abdominal Aortic Aneurysm Market Access and Reimbursement of Therapies

15. Abdominal Aortic Aneurysm Market Drivers

16. Abdominal Aortic Aneurysm Market Barriers

17.  Abdominal Aortic Aneurysm Appendix

18. Abdominal Aortic Aneurysm Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

About DelveInsight 

 

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research
Contact Person: Gaurav Bora
Email: Send Email
Phone: 8774225362
Address:27 Drydock Ave S. Jones Blvd #2432
City: Boston
State: MA
Country: United States
Website: https://www.delveinsight.com/consulting/asset-prioritizaton-services